🟢 Immunic is trading 10% up in pre-market on October 19

Immunic is trading 9.90% higher at $7.66 in pre-market, with no clear company-specific catalyst identified for the rise.

• The price compares with the October 16 close of $6.97.
• The Nasdaq Composite is up 1.24% pre-market, while the supplied biotech-sector context is negative; broad-market sentiment is context, not a confirmed cause.
• Immunic announced Jaa Roberson’s appointment as Chief People Officer on October 19, but no connection to the stock move has been established.